TC BioPharm (Holdings) PLC (TCBP)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 17, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Cash from Investing (TTM): -0.2614M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.2614M |
June 30, 2023 | -0.5402M |
Date | Value |
---|---|
December 31, 2022 | -0.3714M |
June 30, 2022 | -0.1877M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.5402M
Minimum
Jun 2023
-0.1877M
Maximum
Jun 2022
-0.3402M
Average
-0.3164M
Median
Cash from Investing (TTM) Benchmarks
Adaptimmune Therapeutics PLC | 127.84M |
Biodexa Pharmaceuticals Plc | -0.3289M |
NuCana PLC | 3.594M |
Autolus Therapeutics PLC | -10.99M |
Mereo BioPharma Group PLC | -- |